Search research articles
Contact Us
Filters
Showing results (161-170 of 207) with videos related to
Page
of 21
Sort By:
Movement Disorders Clinical Practice
|
June 19, 2023
Impact of the Dopamine System on Long-Term Cognitive Impairment in Parkinson Disease: An Exploratory Study
Daniel Weintraub, Marina Picillo, Hyunkeun Ryan Cho, et al.
JAMA Neurology
|
August 28, 2013
Association of cerebrospinal fluid β-amyloid 1-42, T-tau, P-tau181, and α-synuclein levels with clinical features of drug-naive patients with early Parkinson disease
Ju-Hee Kang, David J Irwin, Alice S Chen-Plotkin, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
March 27, 2019
A specific amino acid motif of <i>HLA-DRB1</i> mediates risk and interacts with smoking history in Parkinson's disease
Jill A Hollenbach, Paul J Norman, Lisa E Creary, et al.
Environmental Health Perspectives
|
January 29, 2011
Rotenone, paraquat, and Parkinson's disease
Caroline M Tanner, Freya Kamel, G Webster Ross, et al.
JMIR Research Protocols
|
August 27, 2025
Improving Prediction of Falls and Cognitive Impairment in Parkinson Disease: Protocol for a Decentralized Observational Study
Audrey Hoyt, Casey Dorney, Peggy Auinger, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
May 4, 2021
Longitudinal Analysis of Multiple Neurotransmitter Metabolites in Cerebrospinal Fluid in Early Parkinson's Disease
Thomas Kremer, Kirsten I Taylor, Juliane Siebourg-Polster, et al.
Nature Biotechnology
|
August 10, 2021
Remote smartphone monitoring of Parkinson's disease and individual response to therapy
Larsson Omberg, Elias Chaibub Neto, Thanneer M Perumal, et al.
Annals of Neurology
|
May 14, 2026
Identification and Enrollment of Individuals Prior to Parkinson's Disease Diagnosis: Biomarker-Driven Adaptive Eligibility and Enrollment into the Parkinson's Progression Markers Initiative
Ethan G Brown, Lana M Chahine, Roseanne D Dobkin, et al.
Neurology. Clinical Practice
|
August 26, 2017
Virtual visits for Parkinson disease: A multicenter noncontrolled cohort
Ryan E Korn, Aparna Wagle Shukla, Maya Katz, et al.
Annals of Neurology
|
December 25, 2024
Staged Screening Identifies People with Biomarkers Related to Neuronal Alpha-Synuclein Disease
Ethan G Brown, Lana M Chahine, Andrew Siderowf, et al.
Page
of 21
Search research articles
Search
Showing results (161-170 of 207) with videos related to
Sort By:
Page
of 21
Movement Disorders Clinical Practice
|
June 19, 2023
Impact of the Dopamine System on Long-Term Cognitive Impairment in Parkinson Disease: An Exploratory Study
Daniel Weintraub, Marina Picillo, Hyunkeun Ryan Cho, et al.
JAMA Neurology
|
August 28, 2013
Association of cerebrospinal fluid β-amyloid 1-42, T-tau, P-tau181, and α-synuclein levels with clinical features of drug-naive patients with early Parkinson disease
Ju-Hee Kang, David J Irwin, Alice S Chen-Plotkin, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
March 27, 2019
A specific amino acid motif of <i>HLA-DRB1</i> mediates risk and interacts with smoking history in Parkinson's disease
Jill A Hollenbach, Paul J Norman, Lisa E Creary, et al.
Environmental Health Perspectives
|
January 29, 2011
Rotenone, paraquat, and Parkinson's disease
Caroline M Tanner, Freya Kamel, G Webster Ross, et al.
JMIR Research Protocols
|
August 27, 2025
Improving Prediction of Falls and Cognitive Impairment in Parkinson Disease: Protocol for a Decentralized Observational Study
Audrey Hoyt, Casey Dorney, Peggy Auinger, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
May 4, 2021
Longitudinal Analysis of Multiple Neurotransmitter Metabolites in Cerebrospinal Fluid in Early Parkinson's Disease
Thomas Kremer, Kirsten I Taylor, Juliane Siebourg-Polster, et al.
Nature Biotechnology
|
August 10, 2021
Remote smartphone monitoring of Parkinson's disease and individual response to therapy
Larsson Omberg, Elias Chaibub Neto, Thanneer M Perumal, et al.
Annals of Neurology
|
May 14, 2026
Identification and Enrollment of Individuals Prior to Parkinson's Disease Diagnosis: Biomarker-Driven Adaptive Eligibility and Enrollment into the Parkinson's Progression Markers Initiative
Ethan G Brown, Lana M Chahine, Roseanne D Dobkin, et al.
Neurology. Clinical Practice
|
August 26, 2017
Virtual visits for Parkinson disease: A multicenter noncontrolled cohort
Ryan E Korn, Aparna Wagle Shukla, Maya Katz, et al.
Annals of Neurology
|
December 25, 2024
Staged Screening Identifies People with Biomarkers Related to Neuronal Alpha-Synuclein Disease
Ethan G Brown, Lana M Chahine, Andrew Siderowf, et al.
Page
of 21